Development and Empirical Evaluation of a Brief Lifestyle Intervention for Older Adults at Risk of Dementia Within an Integrated Medical-Preventive Grid-Based Service Model

by palligoelme@gmail.com | Sep 21, 2026 | Clinical Trials

​ Conditions: Risk of Dementia; Dementia Interventions: Behavioral: Brief lifestyle intervention Sponsors: Fujian Medical University Not yet recruiting Conditions: Risk of Dementia; Dementia Interventions: Behavioral: Brief lifestyle intervention Sponsors: Fujian...

The Potential of Mesenchymal Stromal Stem Cells to Correct Immune and Metabolic Dysfunctions in Circulating Immune Cells During Sepsis: An Ex Vivo Pilot Study.

by palligoelme@gmail.com | Sep 20, 2026 | Clinical Trials

​ Conditions: Sepsis Interventions: Biological: Blood sample; Biological: Blood sample Sponsors: Centre Hospitalier Universitaire Dijon Not yet recruiting Conditions: Sepsis Interventions: Biological: Blood sample; Biological: Blood sample Sponsors: Centre Hospitalier...

4-STEP Training Program for Social Media Addiction, Cognitive Fatigue, Psychological Distress, Academic Burnout and Procrastination Among Students

by palligoelme@gmail.com | Sep 20, 2026 | Clinical Trials

​ Conditions: Social Media Addiction Interventions: Behavioral: 4-STEP-TPS Sponsors: Government College University Faisalabad Not yet recruiting Conditions: Social Media Addiction Interventions: Behavioral: 4-STEP-TPS Sponsors: Government College University Faisalabad...

TLI- and ATG-Enabled Minimization Protocol in Liver Transplantation

by palligoelme@gmail.com | Sep 19, 2026 | Clinical Trials

​ Conditions: Liver Failure Interventions: Drug: Anti-Thymocyte Globulin, ATG (Rabbit); Device: Total lymphoid irradiation Sponsors: Stanford University Not yet recruiting Conditions: Liver Failure Interventions: Drug: Anti-Thymocyte Globulin, ATG (Rabbit); Device:...

Laser Photocoagulation and Ranibizumab Treatment in Proliferative Diabetic Retinopathy

by palligoelme@gmail.com | Sep 18, 2026 | Clinical Trials

​ Conditions: Proliferative Diabetic Retinopathy (PDR) Interventions: Drug: Ranibizumab 0.5 mg; Procedure: laser photocoagulation (PRP) Sponsors: Aswan University Completed Conditions: Proliferative Diabetic Retinopathy (PDR) Interventions: Drug: Ranibizumab 0.5 mg;...

Real-World Effectiveness of Depemokimab in Allergic Bronchopulmonary Aspergillosis With Severe Eosinophilic Asthma

by palligoelme@gmail.com | Sep 18, 2026 | Clinical Trials

​ Conditions: Allergic Bronchopulmonary Aspergillosis; ABPA; Severe Eosinophilic Asthma Interventions: Drug: Depemokimab Sponsors: Qianfoshan Hospital Not yet recruiting Conditions: Allergic Bronchopulmonary Aspergillosis; ABPA; Severe Eosinophilic Asthma...